GT
FBT icon

Glenmede Trust’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Glenmede Trust’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-190
Closed -$29K – 1562
2020
Q3 		$29K Hold
190
– – ﹤0.01% 1471
2020
Q2 		$31K Buy
+190
New +$29.8K ﹤0.01% 1438

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Glenmede Trust's FBT Position: Q4 2020 in Review

Glenmede Trust sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2020, closing a stake of 190 shares — an estimated $29K sold.

Glenmede Trust first reported a position in FBT in Q2 2020 and held it in 2 quarters. The position peaked at $31K in Q2 2020. 236 funds tracked by Wall St. Rank hold FBT as of Q4 2020.

  • Glenmede Trust reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 190 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2020, an estimated $29K.
  • Glenmede Trust first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and held it in 2 quarters.
  • Glenmede Trust's First Trust NYSE Arca Biotechnology Index Fund position peaked at $31K in Q2 2020.
  • 236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.